Cargando…

Comparative Analyses of the Clinicopathologic Features of Short-Term and Long-Term Survivors of Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreatoduodenectomy

SIMPLE SUMMARY: In this study, we systematically examined the clinicopathologic characteristics of 60 short-term survivors and 149 long-term survivors and compared them to 352 intermediate-term survivors of pancreatic ductal adenocarcinoma (PDAC) who received NAT and pancreatoduodenectomy. We found...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Tom Z., Katz, Matthew H. G., Prakash, Laura R., Chatterjee, Deyali, Wang, Hua, Kim, Michael, Tzeng, Ching-Wei D., Ikoma, Naruhiko, Wolff, Robert A., Zhao, Dan, Koay, Eugene J., Maitra, Anirban, Kundu, Suprateek, Wang, Huamin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296490/ https://www.ncbi.nlm.nih.gov/pubmed/37370842 http://dx.doi.org/10.3390/cancers15123231

Ejemplares similares

Prognosticators for Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Therapy and Pancreatectomy
por: Tong, Yi Tat, et al.
Publicado: (2023)

Immune Checkpoint Inhibitor-Induced Hepatic Injury: A Clinicopathologic Review
por: Taherian, Mehran, et al.
Publicado: (2022)

3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma
por: Kang, Ya’an, et al.
Publicado: (2022)

NBTXR3, a first-in-class radioenhancer for pancreatic ductal adenocarcinoma: Report of first patient experience
por: Bagley, Alexander F., et al.
Publicado: (2022)

Pancreatoduodenectomy following neoadjuvant chemotherapy in duodenal adenocarcinoma
por: Seo, Dongjin, et al.
Publicado: (2023)

Regional pancreatoduodenectomy versus standard pancreatoduodenectomy with portal vein resection for pancreatic ductal adenocarcinoma with portal vein invasion
por: Oba, A., et al.
Publicado: (2020)

Impact of preoperative statin medication on long-term outcomes after pancreatoduodenectomy for ductal adenocarcinoma: an international multicentric cross-sectional study
por: Joliat, Gaëtan-Romain, et al.
Publicado: (2023)

SMAD4 Regulates Cell Motility through Transcription of N-Cadherin in Human Pancreatic Ductal Epithelium
por: Kang, Ya'an, et al.
Publicado: (2014)

Reduced expression of argininosuccinate synthetase 1 has a negative prognostic impact in patients with pancreatic ductal adenocarcinoma
por: Liu, Qingqing, et al.
Publicado: (2017)

External pancreatic ductal stenting in minimally invasive pancreatoduodenectomy: How to do it?
por: Gurram, Ram Prakash, et al.
Publicado: (2023)

Predictive Modeling for Voxel-Based Quantification of Imaging-Based Subtypes of Pancreatic Ductal Adenocarcinoma (PDAC): A Multi-Institutional Study
por: Zaid, Mohamed, et al.
Publicado: (2020)

Long-term outcomes of standard versus extended lymphadenectomy in pancreatoduodenectomy for pancreatic ductal adenocarcinoma: A Chinese multi-center prospective randomized controlled trial
por: WANG, Weishen, et al.
Publicado: (2022)

Impact of Diabetes on Short-Term and Long-Term Outcomes of Ampullary Adenocarcinoma Patients after Curative Pancreatoduodenectomy
por: Zhang, Xiaojie, et al.
Publicado: (2022)

Comment on: “Reassessment of the Optimal Number of Examined Lymph Nodes in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma”
por: Zheng, Yangyang, et al.
Publicado: (2023)

Oncological outcomes after pancreatoduodenectomy for pancreatic ductal adenocarcinoma in octogenarians: case-control study
por: Pande, Rupaly, et al.
Publicado: (2023)

Nomograms predict long-term survival for patients with periampullary adenocarcinoma after pancreatoduodenectomy
por: He, Chaobin, et al.
Publicado: (2018)

Impact of Age on Short- and Long-Term Outcomes after Pancreatoduodenectomy for Periampullary Neoplasms
por: Gruppo, Mario, et al.
Publicado: (2020)

Influence of Hemorrhagic Complications of Pancreatoduodenectomy in Patients with Cancer on Short- and Long-Term Mortality
por: Thobie, Alexandre, et al.
Publicado: (2023)

Quantitative imaging to evaluate malignant potential of IPMNs
por: Hanania, Alexander N., et al.
Publicado: (2016)

Recent Advances in Pancreatic Ductal Adenocarcinoma: Strategies to Optimise the Perioperative Nutritional Status in Pancreatoduodenectomy Patients
por: Halle-Smith, James M., et al.
Publicado: (2023)

Rare, long-term complication after pancreatoduodenectomy—a case report of cecal volvulus
por: Nofi, Colleen P, et al.
Publicado: (2021)

Imaging‐based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography scans indicate response to cytotoxic therapy
por: Amer, Ahmed M., et al.
Publicado: (2018)

Pylorus-preserving pancreatoduodenectomy for pancreatic head cancer after surgery for esophageal cancer with gastric tube reconstruction in a long-term survivor: A case report
por: Orii, Takashi, et al.
Publicado: (2019)

Permanent endoscopic reversal of Roux-en-Y gastric bypass for diagnosis and long-term palliation of pancreatic cancer
por: Hakim, Seifeldin, et al.
Publicado: (2020)

Delayed Gastric Emptying Does Not Influence Cancer-Specific Survival after Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma
por: Pillny, Christiane, et al.
Publicado: (2022)

Hepatic Steatosis After Neoadjuvant Chemotherapy for Pancreatic Cancer: Incidence and Implications for Outcomes After Pancreatoduodenectomy
por: Flick, K. F., et al.
Publicado: (2020)

Neoadjuvant FOLFIRINOX Followed by Pancreatoduodenectomy for Pancreatic Cancer in Patients with Previous Transhiatal Esophagectomy for Esophageal Cancer
por: Kim, Juwan, et al.
Publicado: (2022)

Effects of Serum Lipids on the Long-Term Prognosis of Ampullary Adenocarcinoma Patients after Curative Pancreatoduodenectomy
por: Li, Zheng, et al.
Publicado: (2022)

Impact of KRAS Mutations and Co-mutations on Clinical Outcomes in Pancreatic Ductal Adenocarcinoma
por: Yousef, Abdelrahman, et al.
Publicado: (2023)

Molecular Characteristics of Pancreatic Ductal Adenocarcinoma
por: Ottenhof, Niki A., et al.
Publicado: (2011)

Clinicopathological findings of a long-term survivor of V180I genetic Creutzfeldt-Jakob disease
por: Hayashi, Yuichi, et al.
Publicado: (2020)

Comparison of Minimally Invasive versus Open Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: A Propensity Score Matching Analysis
por: Kwon, Jaewoo, et al.
Publicado: (2020)

Importance of Nodal Metastases Location in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: Results from a Prospective, Lymphadenectomy Protocol
por: Malleo, Giuseppe, et al.
Publicado: (2022)

Pancreaticogastrostomy After Pancreatoduodenectomy
por: Sauvanet, A., et al.
Publicado: (1992)

The tube, the pancreatoduodenectomy—and the dogma
por: Lassen, Kristoffer
Publicado: (2021)

Genetics and biology of pancreatic ductal adenocarcinoma
por: Ying, Haoqiang, et al.
Publicado: (2016)

Risk of breast cancer according to clinicopathologic features among long-term survivors of Hodgkin's lymphoma treated with radiotherapy
por: Dores, G M, et al.
Publicado: (2010)

Oncological outcomes of robotic-assisted versus open pancreatoduodenectomy for pancreatic ductal adenocarcinoma: a propensity score-matched analysis
por: Weng, Yuanchi, et al.
Publicado: (2020)

Pancreatoduodenectomy, fifteen years of experience
por: Ruiz-Molina, Juan, et al.
Publicado: (2007)

THE OBITUARY OF THE PYLORUS-PRESERVING PANCREATODUODENECTOMY
por: TORRES, Orlando Jorge Martins, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_mh10lpbpsl1ju3qrp53ef38gre